Cargando…

Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance

OBJECTIVE: To assess the validity of an exposure score obtained from the Xm(2) tool for all pharmacological and nonpharmacological strategies used by individuals to manage chronic pain. METHODS: Using data from individuals with chronic pain, eXposure multimodal (Xm(2)) scores were calculated by assi...

Descripción completa

Detalles Bibliográficos
Autores principales: Axon, David Rhys, Bhattacharjee, Sandipan, Warholak, Terri L., Slack, Marion K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311733/
https://www.ncbi.nlm.nih.gov/pubmed/30651900
http://dx.doi.org/10.1155/2018/2530286
_version_ 1783383655899463680
author Axon, David Rhys
Bhattacharjee, Sandipan
Warholak, Terri L.
Slack, Marion K.
author_facet Axon, David Rhys
Bhattacharjee, Sandipan
Warholak, Terri L.
Slack, Marion K.
author_sort Axon, David Rhys
collection PubMed
description OBJECTIVE: To assess the validity of an exposure score obtained from the Xm(2) tool for all pharmacological and nonpharmacological strategies used by individuals to manage chronic pain. METHODS: Using data from individuals with chronic pain, eXposure multimodal (Xm(2)) scores were calculated by assigning one point for every 100 mg of morphine equivalent used (opioid medications); 25% of the maximum recommended exposure used (nonopioid medications); and any use of another strategy then summed. Content, criterion, construct, and convergent validity were assessed. RESULTS: The sample of 149 individuals used a mean of 12.6 (SD = 4.6) strategies to manage pain and had a mean Xm(2) score of 16.8 (SD = 9.1). Content validity was established by demonstrating that the pain management strategies identified were also reported in the literature. Criterion validity was established by the positive association of exposure scores with the following: interference with work (odds ratio (OR) = 2.23, 95% confidence interval (CI) = 1.14–4.36), daily activities (OR = 2.10, CI = 1.07–4.13), relationships (OR = 1.98, CI = 1.01–3.88), and leisure activities (OR = 2.31, CI = 1.18–4.50); workdays missed (OR = 5.10, CI = 1.92–13.58); emergency department visits (OR = 3.40, CI = 1.17–9.91); hospitalizations (OR = 4.18, CI = 0.86–20.37); and by a negative association with satisfaction (OR = 0.40, CI = 0.18–0.88). Construct validity was established by the positive association of exposure with baseline pain intensity (p < 0.01) and odds of experiencing an adverse event (OR = 2.31, CI = 1.18–4.52). Convergent validity was established through correlations of pain intensity from the Xm(2) score and existing quantitative analgesic questionnaire (QAQ) score. DISCUSSION: Xm(2) scores represent a valid estimate of total exposure to multimodal strategies used and provide clinically relevant information for deciding what strategies to use at what level.
format Online
Article
Text
id pubmed-6311733
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63117332019-01-16 Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance Axon, David Rhys Bhattacharjee, Sandipan Warholak, Terri L. Slack, Marion K. Pain Res Manag Research Article OBJECTIVE: To assess the validity of an exposure score obtained from the Xm(2) tool for all pharmacological and nonpharmacological strategies used by individuals to manage chronic pain. METHODS: Using data from individuals with chronic pain, eXposure multimodal (Xm(2)) scores were calculated by assigning one point for every 100 mg of morphine equivalent used (opioid medications); 25% of the maximum recommended exposure used (nonopioid medications); and any use of another strategy then summed. Content, criterion, construct, and convergent validity were assessed. RESULTS: The sample of 149 individuals used a mean of 12.6 (SD = 4.6) strategies to manage pain and had a mean Xm(2) score of 16.8 (SD = 9.1). Content validity was established by demonstrating that the pain management strategies identified were also reported in the literature. Criterion validity was established by the positive association of exposure scores with the following: interference with work (odds ratio (OR) = 2.23, 95% confidence interval (CI) = 1.14–4.36), daily activities (OR = 2.10, CI = 1.07–4.13), relationships (OR = 1.98, CI = 1.01–3.88), and leisure activities (OR = 2.31, CI = 1.18–4.50); workdays missed (OR = 5.10, CI = 1.92–13.58); emergency department visits (OR = 3.40, CI = 1.17–9.91); hospitalizations (OR = 4.18, CI = 0.86–20.37); and by a negative association with satisfaction (OR = 0.40, CI = 0.18–0.88). Construct validity was established by the positive association of exposure with baseline pain intensity (p < 0.01) and odds of experiencing an adverse event (OR = 2.31, CI = 1.18–4.52). Convergent validity was established through correlations of pain intensity from the Xm(2) score and existing quantitative analgesic questionnaire (QAQ) score. DISCUSSION: Xm(2) scores represent a valid estimate of total exposure to multimodal strategies used and provide clinically relevant information for deciding what strategies to use at what level. Hindawi 2018-12-12 /pmc/articles/PMC6311733/ /pubmed/30651900 http://dx.doi.org/10.1155/2018/2530286 Text en Copyright © 2018 David Rhys Axon et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Axon, David Rhys
Bhattacharjee, Sandipan
Warholak, Terri L.
Slack, Marion K.
Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance
title Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance
title_full Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance
title_fullStr Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance
title_full_unstemmed Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance
title_short Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance
title_sort xm(2) scores for estimating total exposure to multimodal strategies identified by pharmacists for managing pain: validity testing and clinical relevance
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311733/
https://www.ncbi.nlm.nih.gov/pubmed/30651900
http://dx.doi.org/10.1155/2018/2530286
work_keys_str_mv AT axondavidrhys xm2scoresforestimatingtotalexposuretomultimodalstrategiesidentifiedbypharmacistsformanagingpainvaliditytestingandclinicalrelevance
AT bhattacharjeesandipan xm2scoresforestimatingtotalexposuretomultimodalstrategiesidentifiedbypharmacistsformanagingpainvaliditytestingandclinicalrelevance
AT warholakterril xm2scoresforestimatingtotalexposuretomultimodalstrategiesidentifiedbypharmacistsformanagingpainvaliditytestingandclinicalrelevance
AT slackmarionk xm2scoresforestimatingtotalexposuretomultimodalstrategiesidentifiedbypharmacistsformanagingpainvaliditytestingandclinicalrelevance